Converting enzyme inhibition and heart failure
- 11 March 1988
- journal article
- clinical trial
- Published by Elsevier
- Vol. 84 (3) , 87-91
- https://doi.org/10.1016/0002-9343(88)90210-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.Circulation, 1984
- Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.Circulation, 1983
- Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.Circulation, 1983
- Regional and systemic metabolic effects of angiotensin-converting enzyme inhibition during exercise in patients with severe heart failure.Circulation, 1982
- Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.Circulation, 1982
- Angiotensin inhibition in severe heart failure: Acute central and limb hemodynamic effects of captopril with observations on sustained oral therapyAmerican Heart Journal, 1981
- Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.Circulation, 1980
- Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1980
- Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.Circulation, 1980
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979